Non-Myeloablative Allogeneic Transplantation
Springer-Verlag New York Inc.
978-1-4613-5304-1 (ISBN)
1 Development of allogeneic hematopoietic stem cell transplantation (HSCT).- 2 Immunosuppression with limited toxicity: the characteristics of nucleoside analogs and anti-lymphocyte antibodies used in nonmyeloablative hematopoietic cell transplantation.- 3 Mobilization of allogeneic peripheral blood progenitor cells.- 4 Non-myeloblative induction of mixed hematopoietic chimerism: application to transplantation tolerance and hematologicmalignancies in experimental and clinical studies.- 5 Combined use of autografting and non-myeloablative allografting for the treatment of hematologic malignancies and metastatic breast cancer.- 6 Non-myeloablative hematopoietic stem cell transplantation (NST) in the treatment of human malignancies: from animal models to clinical practice.- 7 Non-myeloablative allogeneic hematopoietic transplantation and induction of graft-versus-malignancy.- 8 Outpatient allografting in hematologic malignancies and nonmalignant disorders — applying lessons learned in the canine model to humans.- 9 Non-myeloablative transplants for congenital diseases.
Reihe/Serie | Cancer Treatment and Research ; 110 |
---|---|
Zusatzinfo | X, 216 p. |
Verlagsort | New York, NY |
Sprache | englisch |
Maße | 155 x 235 mm |
Themenwelt | Medizin / Pharmazie ► Medizinische Fachgebiete ► Chirurgie |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Onkologie | |
ISBN-10 | 1-4613-5304-1 / 1461353041 |
ISBN-13 | 978-1-4613-5304-1 / 9781461353041 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
aus dem Bereich